Natixis Advisors LLC lowered its position in shares of Globe Life Inc. (NYSE:GL - Free Report) by 12.3% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 114,593 shares of the company's stock after selling 16,073 shares during the quarter. Natixis Advisors LLC owned 0.14% of Globe Life worth $12,779,000 as of its most recent SEC filing.
A number of other institutional investors have also recently bought and sold shares of GL. CIBC Asset Management Inc boosted its holdings in shares of Globe Life by 13.3% in the third quarter. CIBC Asset Management Inc now owns 12,777 shares of the company's stock valued at $1,353,000 after buying an additional 1,495 shares during the period. Mutual of America Capital Management LLC boosted its holdings in shares of Globe Life by 4.4% in the third quarter. Mutual of America Capital Management LLC now owns 11,060 shares of the company's stock valued at $1,171,000 after buying an additional 471 shares during the period. Thrivent Financial for Lutherans boosted its holdings in shares of Globe Life by 4.0% in the third quarter. Thrivent Financial for Lutherans now owns 3,524 shares of the company's stock valued at $373,000 after buying an additional 136 shares during the period. Quest Partners LLC boosted its holdings in shares of Globe Life by 139,166.7% in the third quarter. Quest Partners LLC now owns 4,178 shares of the company's stock valued at $442,000 after buying an additional 4,175 shares during the period. Finally, Segall Bryant & Hamill LLC boosted its holdings in shares of Globe Life by 78.5% in the third quarter. Segall Bryant & Hamill LLC now owns 290,515 shares of the company's stock valued at $30,768,000 after buying an additional 127,764 shares during the period. Institutional investors and hedge funds own 81.61% of the company's stock.
Globe Life Stock Performance
NYSE GL traded down $1.74 on Friday, hitting $126.86. 1,735,122 shares of the stock were exchanged, compared to its average volume of 1,402,574. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.05 and a quick ratio of 0.05. The business's fifty day moving average is $122.53 and its 200 day moving average is $112.98. Globe Life Inc. has a 52 week low of $38.95 and a 52 week high of $131.39. The company has a market capitalization of $10.64 billion, a PE ratio of 10.62 and a beta of 0.77.
Globe Life (NYSE:GL - Get Free Report) last posted its quarterly earnings results on Wednesday, February 5th. The company reported $3.14 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.12 by $0.02. Globe Life had a net margin of 18.53% and a return on equity of 22.32%. Research analysts anticipate that Globe Life Inc. will post 13.87 EPS for the current fiscal year.
Globe Life Increases Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, May 1st. Stockholders of record on Thursday, April 3rd will be given a $0.27 dividend. The ex-dividend date of this dividend is Thursday, April 3rd. This is a positive change from Globe Life's previous quarterly dividend of $0.24. This represents a $1.08 annualized dividend and a dividend yield of 0.85%. Globe Life's dividend payout ratio is presently 9.04%.
Insider Activity
In other news, Director Mark A. Blinn sold 3,000 shares of the stock in a transaction dated Monday, January 6th. The shares were sold at an average price of $113.23, for a total value of $339,690.00. Following the transaction, the director now directly owns 5,122 shares of the company's stock, valued at $579,964.06. This represents a 36.94 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Frank M. Svoboda sold 13,448 shares of the company's stock in a transaction dated Monday, January 6th. The shares were sold at an average price of $112.56, for a total transaction of $1,513,706.88. Following the completion of the transaction, the chief executive officer now owns 18,948 shares in the company, valued at $2,132,786.88. This trade represents a 41.51 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 61,338 shares of company stock valued at $7,239,630 over the last ninety days. 1.51% of the stock is currently owned by company insiders.
Analyst Ratings Changes
GL has been the subject of several recent research reports. Evercore ISI upgraded shares of Globe Life from an "in-line" rating to an "outperform" rating and increased their target price for the stock from $132.00 to $143.00 in a report on Wednesday, January 8th. BMO Capital Markets initiated coverage on shares of Globe Life in a report on Thursday, January 23rd. They set a "market perform" rating and a $114.00 target price for the company. Keefe, Bruyette & Woods increased their target price on shares of Globe Life from $137.00 to $145.00 and gave the stock an "outperform" rating in a report on Wednesday, February 12th. Jefferies Financial Group increased their target price on shares of Globe Life from $107.00 to $114.00 and gave the stock a "hold" rating in a report on Tuesday, December 10th. Finally, Wells Fargo & Company increased their target price on shares of Globe Life from $126.00 to $141.00 and gave the stock an "overweight" rating in a report on Wednesday, February 19th. Five research analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $135.60.
Read Our Latest Report on Globe Life
About Globe Life
(
Free Report)
Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.
Recommended Stories

Before you consider Globe Life, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Globe Life wasn't on the list.
While Globe Life currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.